Form 4: BeiGene Executive Lai Wang Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Lai Wang, Global Head of R&D at BeiGene, Ltd., sold shares to cover tax obligations related to vesting restricted share units.
Summary
- Lai Wang, Global Head of R&D at BeiGene, sold American Depositary Shares (ADS) on June 17 and 18, 2024.
- The sales were executed to cover mandatory tax withholding obligations related to the vesting of restricted share units.
- On June 17, 2024, Wang sold 237 ADSs at $158.5002, 478 ADSs at $158.9981, 485 ADSs at $159.4241, and 300 ADSs at $159.9019.
- On June 18, 2024, Wang sold 841 ADSs at $153.7512.
- Following these transactions, Wang directly owns 1,738,529 ordinary shares and indirectly owns 58,188 ordinary shares through Wang Holdings LLC.
- Wang also has an indirect economic interest in RMB Shares through the RMB Shares Employee Participation Plan, to which he contributed RMB10 million.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing detailing share sales for tax purposes. It doesn't indicate any significant positive or negative sentiment regarding the company's performance or future prospects.
Industry Context
Share sales by executives are a common occurrence, often related to tax obligations or diversification of assets. The details provided in the Form 4 filing ensure transparency regarding insider transactions.
Comparison to Industry Standards
- Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, as mandated by the SEC.
- Similar filings are common among executives at comparable biotech companies like Amgen, Gilead Sciences, and Regeneron, when they exercise stock options or sell shares.
- The weighted average pricing and detailed transaction information provided are consistent with SEC requirements for transparency.
Key Dates
| Date | Description |
|---|---|
| 06/15/2023 | 1/4th of the securities will vest on each anniversary of this date, subject to continued service. |
| 06/16/2021 | 1/4th of the securities will vest on each anniversary of this date, subject to continued service. |
| 06/17/2020 | 1/4th of the securities will vest on each anniversary of this date, subject to continued service. |
| 06/17/2024 | Sale of American Depositary Shares. |
| 06/18/2024 | Sale of American Depositary Shares. |
| 06/20/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.